2021-06596. Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction  

  • Start Preamble Start Printed Page 16667

    AGENCY:

    Drug Enforcement Administration, Department of Justice.

    ACTION:

    Final rule; correcting amendment.

    SUMMARY:

    The Drug Enforcement Administration is correcting a final rule that appeared in the Federal Register on November 25, 2020. The document issued an action placing five fentanyl-related substances (cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide), isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide), para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide), para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide), and valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, permanently in schedule I of the Controlled Substances Act, specifically to the opiates list under DEA regulations. The published document assigned incorrect paragraph numbers to all five substances, and inadvertently removed four other substances from the listed opiates.

    DATES:

    Effective date: March 31, 2021.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Terrence L. Boos, Drug and Chemical Evaluation Section, Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-3249.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    On November 25, 2020, the Drug Enforcement Administration (DEA) permanently placed five fentanyl-related substances (cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide), isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide), para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide), para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide), and valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) in schedule I of the Controlled Substances Act (CSA), specifically to the opiates list under 21 CFR 1308.11(b). 85 FR 75231. The final rule incorrectly assigned paragraph numbers 22, 40, 56, and 59 under paragraph (b) to cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, and para-methoxybutyryl fentanyl, respectively, overriding previously assigned paragraph numbers for four listed opiates crotonyl fentanyl, ketobemidone, para-fluorofentanyl, and phenampromide (i.e., (b)(22), (40), (56), and (59)). In addition, the final rule incorrectly added valeryl fentanyl as a new paragraph (b)(75) instead of (b)(76). This document updates the numbering of all listed opiates in paragraph (b), and specifically corrects the paragraph numbers for cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl, and reassigns paragraph numbers for crotonyl fentanyl, ketobemidone, para-fluorofentanyl, and phenampromide. It bears emphasis that DEA still considers the four substances (crotonyl fentanyl, ketobemidone, para-fluorofentanyl, and phenampromide) to have been schedule I substances during the time period from the issuance of the November 25, 2020, final rule to this correction, despite these inadvertent numbering errors.[1]

    Start List of Subjects

    List of Subjects in 21 CFR Part 1308

    • Administrative practice and procedure
    • Drug traffic control
    • Reporting and recordkeeping requirements
    End List of Subjects

    For the reasons set out above, 21 CFR part 1308 is amended as follows:

    Start Part

    PART 1308—SCHEDULES OF CONTROLLED SUBSTANCES

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 1308 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise noted.

    End Authority Start Amendment Part

    2. In § 1308.11(b), revise the table to read as follows:

    End Amendment Part
    Schedule I.
    * * * * *

    (b) * * *

    (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)9815
    (2) Acetylmethadol9601
    (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821
    (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl)9811
    (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)9551
    (6) Allylprodine9602
    (7) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)9603
    (8) Alphameprodine9604
    (9) Alphamethadol9605
    Start Printed Page 16668
    (10) alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine)9814
    (11) alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)9832
    (12) Benzethidine9606
    (13) Betacetylmethadol9607
    (14) beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)9830
    (15) beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide)9831
    (16) beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)9836
    (17) Betameprodine9608
    (18) Betamethadol9609
    (19) Betaprodine9611
    (20) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide)9822
    (21) Clonitazene9612
    (22) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)9844
    (23) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide)9847
    (24) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide)9845
    (25) Dextromoramide9613
    (26) Diampromide9615
    (27) Diethylthiambutene9616
    (28) Difenoxin9168
    (29) Dimenoxadol9617
    (30) Dimepheptanol9618
    (31) Dimethylthiambutene9619
    (32) Dioxaphetyl butyrate9621
    (33) Dipipanone9622
    (34) Ethylmethylthiambutene9623
    (35) Etonitazene9624
    (36) Etoxeridine9625
    (37) 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl)9824
    (38) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)9834
    (39) Furethidine9626
    (40) Hydroxypethidine9627
    (41) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide)9827
    (42) Ketobemidone9628
    (43) Levomoramide9629
    (44) Levophenacylmorphan9631
    (45) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9825
    (46) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)9813
    (47) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide)9833
    (48) Morpheridine9632
    (49) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)9661
    (50) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)9560
    (51) Noracymethadol9633
    (52) Norlevorphanol9634
    (53) Normethadone9635
    (54) Norpipanone9636
    (55) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide)9838
    (56) ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl)9816
    (57) para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)9826
    (58) para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)9823
    (59) para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide)9812
    (60) para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)9837
    (61) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine)9663
    (62) Phenadoxone9637
    (63) Phenampromide9638
    (64) Phenomorphan9647
    (65) Phenoperidine9641
    (66) Piritramide9642
    (67) Proheptazine9643
    (68) Properidine9644
    (69) Propiram9649
    (70) Racemoramide9645
    (71) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide)9843
    (72) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide)9835
    (73) Tilidine9750
    (74) Trimeperidine9646
    (75) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)9547
    (76) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide)9840
    Start Printed Page 16669
    * * * * *
    Start Signature

    D. Christopher Evans,

    Acting Administrator.

    End Signature End Supplemental Information

    Footnotes

    1.  Under the CSA, a controlled substance may only be removed from the schedules, or transferred to another schedule, where DEA expressly does so by a scheduling action issued in accordance with 21 U.S.C. 811 and published in the Federal Register. DEA took no such action with respect to crotonyl fentanyl, ketobemidone, para-fluorofentanyl, and phenampromide. Accordingly, the scheduling status of these four substances was never altered by the final rule that appeared in the Federal Register on November 25, 2020.

    Back to Citation

    [FR Doc. 2021-06596 Filed 3-30-21; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Effective Date:
3/31/2021
Published:
03/31/2021
Department:
Drug Enforcement Administration
Entry Type:
Rule
Action:
Final rule; correcting amendment.
Document Number:
2021-06596
Dates:
Effective date: March 31, 2021.
Pages:
16667-16669 (3 pages)
Docket Numbers:
Docket No. DEA-565
Topics:
Administrative practice and procedure, Drug traffic control, Reporting and recordkeeping requirements
PDF File:
2021-06596.pdf
Supporting Documents:
» Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction
CFR: (1)
21 CFR 1308.11